Efficacy of Ashwagandha Ghrita as Matra Basti and Shamana Snehapana in improving quality of life in geriatric population â?? An Open Labelled Randomized Placebo Control Comparative Clinical Trial.
Phase 3
Not yet recruiting
- Registration Number
- CTRI/2022/03/041398
- Lead Sponsor
- Institute of Teaching and Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Apparently healthy individual between the age of 60 years to 80 years.
Willing and able to participate in the study.
Individuals with controlled systemic diseases.
Individuals fit for Shamana Snehapana or Matra Basti in respective group.
Exclusion Criteria
Individuals below the age of 60 years and above the age of 80 years.
Individuals having uncontrolled systemic diseases like HTN, DM, active neoplastic
disease etc. will be excluded.
Individuals unfit for Shamana Snehapana or Matra Basti in respective group.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Ashwagandha Ghrita's effects in geriatric QoL improvement?
How does Ashwagandha Ghrita compare to standard-of-care treatments for geriatric quality of life?
Are there specific biomarkers that predict response to Ayurvedic therapies like Matra Basti and Shamana Snehapana?
What are the potential adverse events associated with Ashwagandha Ghrita in elderly patients?
What combination approaches or competitor drugs exist for geriatric quality of life improvement in Ayurveda?